Results 201 to 210 of about 50,715 (282)
Fatalities in opioid agonist treatment with long-acting injectable buprenorphine. [PDF]
Häkkinen M +3 more
europepmc +1 more source
In a parallel, placebo‐controlled study with direct gas infusion into the stomach, STW 5‐II reduced the perception of abdominal symptoms in patients with dyspepsia complaining of bloating when compared to placebo, with a minor effect on gas transit and evacuation, and no effect on visible abdominal distension.
Ariadna Aguilar +6 more
wiley +1 more source
Clinical Management of Synthetic-Cannabinoid-Induced Psychosis: A Systematic Review of Treatment Strategies and Outcomes. [PDF]
Mosca A +6 more
europepmc +1 more source
Portal venous drainage in a swine model of living‐donor intestinal transplantation promoted a more balanced immunometabolic profile, with early apoptotic modulation and increased IL‐1α expression, suggesting improved mucosal adaptation compared with systemic drainage.
Guilherme F. Paganoti +7 more
wiley +1 more source
Statewide Prehospital Buprenorphine in Delaware: Two-Years of Paramedic-Initiated Medication for Opioid Use Disorder After Overdose. [PDF]
Wanner GK, Dworkin M, Rosenbaum RA.
europepmc +1 more source
Aging and the Spectral Properties of Brain Hemodynamics
As the brain ages, its metabolic demands decline—but not uniformly. Here, spectral slope flattening of resting‐state fMRI signals is proposed as a potential biomarker of pathologic brain aging. A subset of older adults diverges from youthful spectral and metabolic patterns, with changes linked to frontal white matter pathology and regional loss of ...
Ki Yun Park +9 more
wiley +1 more source
Childhood neglects: intimate partner violence in PTSD-SUD comorbid patients treated with narrative exposure therapy. [PDF]
Nolasco Ferreira V +6 more
europepmc +1 more source
The limited understanding of IGFR pathway activation hinders its clinical application in HCC. Here, IGFRIL is identified as a novel non‐coding activator of the IGF1R, which recruits PTBP1 to destabilize IGFBP3 mRNA and activates IGF1R, and proposes IGFRIL as a novel actionable target for HCC patients.
Jing Zhang +28 more
wiley +1 more source
Discriminating evidence - use and misuse of the drug-discrimination test in abuse potential assessment of novel CNS drugs. [PDF]
Heal DJ, Smith SL, Gosden J, Rowlett J.
europepmc +1 more source
Rationally engineered AIE nanoparticles can unite deep‐tissue imaging, photodynamic therapy, photothermal therapy, and immune microenvironment reprogramming. Through precise photophysical tuning and targeted delivery, these intelligent nanoplatforms enable real‐time monitoring, potent tumor eradication, and immune activation, offering a versatile and ...
Quazi T. H. Shubhra +5 more
wiley +1 more source

